CSI Market
Sign In | Register

Cormedix Inc (CRMD) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access CRMD Annual Cash Flow →
This cash flow overview for Cormedix Inc spans from Jun 30 2025 to Jun 30 2026, illustrating how cash generation and usage have shifted across recent reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Jun 30 2026)
6 Months 		(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Operating Activities
Income64.59
Depreciation & amortization21.08
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges-10.85
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories8.87
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation8.67
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants1.00
Expense Warrants Issued In Connection With License Agreement-
Loss On Issuance Of Convertible Notes And Warrants-
Increase Decrease Accrued Expenses And Accrued Interest-
Warrants Issued In Connection With License Agreement-
Noncash Charges And Other-
Value Of Warrants Issued In Connection With Backstop Financing-
Modification Of Warrant Agreement-
Loss On Issuance Of Warrants And Preferred Stock-
Fair Value Option Changes In Fair Value Gain Loss-
Issuance Of Common Stock For Vested Restricted Stock Units-
Noncash Interest Expense-
Increase Decrease In Accrued Expenses-
Deemed Dividend As A Result Of Warrant Modification-
Noncash Lease Expense-
Operating Lease Right Of Use Asset Amortization Expense-
Payment Of Contingent Consideration Liabilities Operating Activities-0.22
Increase Decrease In Operating Lease Liability-
Income taxes0.00
Unrealized Gain (Loss) on Investments0.00
Increase (Decrease) in Accounts Receivable-10.01
Increase (Decrease) in Accounts Payable2.17
Increase (Decrease) in Accrued Liabilities8.35
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets7.35
Other Working Capital0.00
Other Noncash Income (Expense)-1.40
Other net0.00
Payments for (Proceeds from) Other Operating Activities28.82
Discontinued operations0.00
Net Cash flow from Operating Activities128.62
Investing Activities
Capital Expenditures-1.29
Sale of Capital Items0.00
Proceeds from Sale of Short-term Investments3.69
Proceeds from Sale of Trading Securities Held-for-investment0.00
Real Estate Investments0.00
Increase (Decrease) in Restricted Cash0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments to Acquire Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Payments to Acquire Businesses, Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities2.40
Financing Activities
Short-term debt Net0.00
Other borrowing transactions-0.31
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock-16.07
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net-1.66
Other net-1.13
Proceeds From Senior Convertible Notes Related Party-
Proceeds From Senior Convertible Notes Related Party Net-
Proceeds From Series C3 Preferred Stock Net-
Proceeds From Series C3 Preferred Stock Related Party-
Proceeds From Short Swing Profit Recovery-
Proceeds From Notes Payable Related Party-
Payment Of Debt Issuance Costs In Connection With Senior Convertible Note-
Payment Of Employee Withholding Taxes On Vested Restricted Stock Units-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-19.17
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow127.33
Total Cash Flow111.86
4 historic quarters locked

Sign in to unlock the full Cormedix Inc cash flow history.

Sign In Create Free Account

About Cormedix Inc Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001410098-26-000056

Figures are derived from filed reports and may be restated. Historical data is subject to revision.